Author

Britt K. Erickson

Unknown affiliation - Cited by 2,003

Biography

Dr. Britt K. Erickson is a Professor and Full-time researcher in the Department of Obstetrics and Gynecology, University of Minnesota, School of Medicine, Minneapolis, USA. Author research interests include Gynaecology, Obestrics, palliative care, etc., Author has several publications and reports in Gynaecology and Maternal Health.
Title
Cited by
Year
Feasibility of complete salpingectomy compared with standard postpartum tubal ligation at cesarean delivery: a randomized controlled trial
A Subramaniam, CT Blanchard, BK Erickson, J Szychowski, CA Leath, ...Obstetrics and gynecology 132 (1), 20, 2018201
50
2018
The DNA cytosine deaminase APOBEC3B is a molecular determinant of platinum responsiveness in clear cell ovarian cancer
AA Serebrenik, PP Argyris, MC Jarvis, WL Brown, M Bazzaro, RI Vogel, ...Clinical Cancer Research 26 (13), 3397-3407, 2020202
44
2020
An innovative medical school curriculum to address human papillomavirus vaccine hesitancy
AM Schnaith, EM Evans, C Vogt, AM Tinsay, TE Schmidt, KM Tessier, ...Vaccine 36 (26), 3830-3835, 2018201
40
2018
Human epidermal growth factor 2 (HER2) in early stage uterine serous carcinoma: a multi-institutional cohort study
BK Erickson, O Najjar, S Damast, A Blakaj, J Tymon-Rosario, M Shahi, ...Gynecologic oncology 159 (1), 17-22, 2020202
36
2020
Uterine serous carcinoma: key advances and novel treatment approaches
JS Ferriss, BK Erickson, IM Shih, AN FaderInternational Journal of Gynecologic Cancer 31 (8), 2021202
32
2021
Targeting human epidermal growth factor receptor 2 (HER2) in gynecologic malignancies
BK Erickson, B Zeybek, AD Santin, AN FaderCurrent opinion in obstetrics & gynecology 32 (1), 57, 2020202
27
2020
The cost-effectiveness of opportunistic salpingectomy versus standard tubal ligation at the time of cesarean delivery for ovarian cancer risk reduction
A Subramaniam, BD Einerson, CT Blanchard, BK Erickson, J Szychowski, ...Gynecologic oncology 152 (1), 127-132, 2019201
24
2019
High rates of high-grade cervical dysplasia in high-risk young women with low-grade cervical cytology
LR Daily, BK Erickson, DN Pasko, JM Straughn Jr, WK Huh, CA Leath IIIJournal of lower genital tract disease 22 (3), 207, 2018201
14
2018
Role of adjuvant radiation or re-excision for early stage vulvar squamous cell carcinoma with positive or close surgical margins
SM Bedell, C Hedberg, A Griffin, H Pearson, A Wilhite, N Rubin, ...Gynecologic oncology 154 (2), 276-279, 2019201
13
2019
Do differences in medical comorbidities and treatment impact racial disparities in epithelial ovarian cancer?
S Dilley, BK Erickson, CE Phillips, CR Kennemer, B Zhang, T Matin, ...Gynecologic oncology 149 (1), 49-52, 2018201
11
2018
Health care provider adherence to surgical guidelines for risk-reducing salpingo-oophorectomy
AM Wilhite, MC Oestreich, M Olson, SM Bedell, D Westenberg, ...Obstetrics and gynecology 134 (3), 520, 2019201
11
2019
Cervical cancer
JY Martin, BK Erickson, WK HuhEvidence-based Obstet Gynecol, 165-72, 201810201
10
2018
Prospective evaluation of Multinational Association of Supportive Care in Cancer risk index score for gynecologic oncology patients with febrile neutropenia
CC Gunderson, BK Erickson, I Wilkinson-Ryan, SK Vesely, CA Leath, ...American journal of clinical oncology 42 (2), 13, 2019201
8
2019
Molecular profiles of endometrial cancer tumors among Black patients
AM Wilhite, Y Baca, J Xiu, R Paladugu, AC ElNaggar, J Brown, IS Winer, ...Gynecologic oncology 166 (1), 108-116, 2022202
7
2022
Insulin‐like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma
AR Van Arsdale, RC Arend, MJ Cossio, BK Erickson, Y Wang, DW Doo, ...Cancer medicine 7 (3), 1-25, 2018201
6
2018
Müllerian carcinosarcoma arising from atypical pelvic endometriosis
K Amin, B Brumley, BK Erickson, MA KhalifaGynecologic oncology reports 2, 87, 2018201
5
2018
Isolated metastatic pancreatic adenocarcinoma to the uterine cervix: A case report
EM Hartsough, BK Erickson, A Chauhan, MA KhalifaGynecologic Oncology Reports 29, 61-63, 2019201
5
2019
A phase II trial of bevacizumab and rucaparib in recurrent carcinoma of the cervix or endometrium
CG Jackson, KN Moore, L Cantrell, BK Erickson, LR Duska, ...Gynecologic oncology 166 (1), 44-49, 2022202
3
2022
HER2 in uterine serous carcinoma: testing platforms and implications for targeted therapy
HER in uterine serous carcinoma: testing platforms and implications for targeted therapyTR Klc, S Wu, AM Wilhite, NL Jones, MA Powell, A Olawaiye, E Girda, ...Gynecologic oncology 167 (), 89-94, 0
2
2022
Spontaneous transvaginal sigmoid colon evisceration and sepsis from complete procidentia
AM Schefter, J Fischer, BK EricksonFemale pelvic medicine & reconstructive surgery 4 (6), e4, 01801
2
2018

Referred From: https://scholar.google.com/citations?user=oMLRnxYAAAAJ&hl=en

Cited by
Citations 2003
h-index 23
i10-index 35
Recommended Journals
Open Access Journals